1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Precision Cancer Therapeutics Market Size (2020-2031) 2.1.2 Precision Cancer Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) 2.1.3 World Current & Future Analysis for Precision Cancer Therapeutics by Country/Region (2020, 2024 & 2031) 2.2 Precision Cancer Therapeutics Segment by Type 2.2.1 Monoclonal Antibodies 2.2.2 Kinase Inhibitors 2.2.3 Angiogenesis Inhibitors 2.2.4 Proteasome Inhibitors 2.2.5 CAR-T Therapies 2.2.6 Other Precision Therapies 2.3 Precision Cancer Therapeutics Market Size by Type 2.3.1 Precision Cancer Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) 2.3.2 Global Precision Cancer Therapeutics Market Size Market Share by Type (2020-2025) 2.4 Precision Cancer Therapeutics Segment by Application 2.4.1 Breast Cancer 2.4.2 Lung Cancer 2.4.3 Prostate Cancer 2.4.4 Colon and Rectal Cancer 2.4.5 Others 2.5 Precision Cancer Therapeutics Market Size by Application 2.5.1 Precision Cancer Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) 2.5.2 Global Precision Cancer Therapeutics Market Size Market Share by Application (2020-2025) 3 Precision Cancer Therapeutics Market Size by Player 3.1 Precision Cancer Therapeutics Market Size Market Share by Player 3.1.1 Global Precision Cancer Therapeutics Revenue by Player (2020-2025) 3.1.2 Global Precision Cancer Therapeutics Revenue Market Share by Player (2020-2025) 3.2 Global Precision Cancer Therapeutics Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Precision Cancer Therapeutics by Region 4.1 Precision Cancer Therapeutics Market Size by Region (2020-2025) 4.2 Global Precision Cancer Therapeutics Annual Revenue by Country/Region (2020-2025) 4.3 Americas Precision Cancer Therapeutics Market Size Growth (2020-2025) 4.4 APAC Precision Cancer Therapeutics Market Size Growth (2020-2025) 4.5 Europe Precision Cancer Therapeutics Market Size Growth (2020-2025) 4.6 Middle East & Africa Precision Cancer Therapeutics Market Size Growth (2020-2025) 5 Americas 5.1 Americas Precision Cancer Therapeutics Market Size by Country (2020-2025) 5.2 Americas Precision Cancer Therapeutics Market Size by Type (2020-2025) 5.3 Americas Precision Cancer Therapeutics Market Size by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Precision Cancer Therapeutics Market Size by Region (2020-2025) 6.2 APAC Precision Cancer Therapeutics Market Size by Type (2020-2025) 6.3 APAC Precision Cancer Therapeutics Market Size by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Precision Cancer Therapeutics Market Size by Country (2020-2025) 7.2 Europe Precision Cancer Therapeutics Market Size by Type (2020-2025) 7.3 Europe Precision Cancer Therapeutics Market Size by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Precision Cancer Therapeutics by Region (2020-2025) 8.2 Middle East & Africa Precision Cancer Therapeutics Market Size by Type (2020-2025) 8.3 Middle East & Africa Precision Cancer Therapeutics Market Size by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Precision Cancer Therapeutics Market Forecast 10.1 Global Precision Cancer Therapeutics Forecast by Region (2026-2031) 10.1.1 Global Precision Cancer Therapeutics Forecast by Region (2026-2031) 10.1.2 Americas Precision Cancer Therapeutics Forecast 10.1.3 APAC Precision Cancer Therapeutics Forecast 10.1.4 Europe Precision Cancer Therapeutics Forecast 10.1.5 Middle East & Africa Precision Cancer Therapeutics Forecast 10.2 Americas Precision Cancer Therapeutics Forecast by Country (2026-2031) 10.2.1 United States Market Precision Cancer Therapeutics Forecast 10.2.2 Canada Market Precision Cancer Therapeutics Forecast 10.2.3 Mexico Market Precision Cancer Therapeutics Forecast 10.2.4 Brazil Market Precision Cancer Therapeutics Forecast 10.3 APAC Precision Cancer Therapeutics Forecast by Region (2026-2031) 10.3.1 China Precision Cancer Therapeutics Market Forecast 10.3.2 Japan Market Precision Cancer Therapeutics Forecast 10.3.3 Korea Market Precision Cancer Therapeutics Forecast 10.3.4 Southeast Asia Market Precision Cancer Therapeutics Forecast 10.3.5 India Market Precision Cancer Therapeutics Forecast 10.3.6 Australia Market Precision Cancer Therapeutics Forecast 10.4 Europe Precision Cancer Therapeutics Forecast by Country (2026-2031) 10.4.1 Germany Market Precision Cancer Therapeutics Forecast 10.4.2 France Market Precision Cancer Therapeutics Forecast 10.4.3 UK Market Precision Cancer Therapeutics Forecast 10.4.4 Italy Market Precision Cancer Therapeutics Forecast 10.4.5 Russia Market Precision Cancer Therapeutics Forecast 10.5 Middle East & Africa Precision Cancer Therapeutics Forecast by Region (2026-2031) 10.5.1 Egypt Market Precision Cancer Therapeutics Forecast 10.5.2 South Africa Market Precision Cancer Therapeutics Forecast 10.5.3 Israel Market Precision Cancer Therapeutics Forecast 10.5.4 Turkey Market Precision Cancer Therapeutics Forecast 10.6 Global Precision Cancer Therapeutics Forecast by Type (2026-2031) 10.7 Global Precision Cancer Therapeutics Forecast by Application (2026-2031) 10.7.1 GCC Countries Market Precision Cancer Therapeutics Forecast 11 Key Players Analysis 11.1 AbbVie 11.1.1 AbbVie Company Information 11.1.2 AbbVie Precision Cancer Therapeutics Product Offered 11.1.3 AbbVie Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.1.4 AbbVie Main Business Overview 11.1.5 AbbVie Latest Developments 11.2 Astellas Pharma U.S., Inc 11.2.1 Astellas Pharma U.S., Inc Company Information 11.2.2 Astellas Pharma U.S., Inc Precision Cancer Therapeutics Product Offered 11.2.3 Astellas Pharma U.S., Inc Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.2.4 Astellas Pharma U.S., Inc Main Business Overview 11.2.5 Astellas Pharma U.S., Inc Latest Developments 11.3 AstraZeneca PLC 11.3.1 AstraZeneca PLC Company Information 11.3.2 AstraZeneca PLC Precision Cancer Therapeutics Product Offered 11.3.3 AstraZeneca PLC Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.3.4 AstraZeneca PLC Main Business Overview 11.3.5 AstraZeneca PLC Latest Developments 11.4 Bayer AG 11.4.1 Bayer AG Company Information 11.4.2 Bayer AG Precision Cancer Therapeutics Product Offered 11.4.3 Bayer AG Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.4.4 Bayer AG Main Business Overview 11.4.5 Bayer AG Latest Developments 11.5 Bristol-Myers Squibb Company 11.5.1 Bristol-Myers Squibb Company Company Information 11.5.2 Bristol-Myers Squibb Company Precision Cancer Therapeutics Product Offered 11.5.3 Bristol-Myers Squibb Company Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.5.4 Bristol-Myers Squibb Company Main Business Overview 11.5.5 Bristol-Myers Squibb Company Latest Developments 11.6 Clovis Oncology, Inc. 11.6.1 Clovis Oncology, Inc. Company Information 11.6.2 Clovis Oncology, Inc. Precision Cancer Therapeutics Product Offered 11.6.3 Clovis Oncology, Inc. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.6.4 Clovis Oncology, Inc. Main Business Overview 11.6.5 Clovis Oncology, Inc. Latest Developments 11.7 Dendreon Pharmaceuticals LLC 11.7.1 Dendreon Pharmaceuticals LLC Company Information 11.7.2 Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Product Offered 11.7.3 Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.7.4 Dendreon Pharmaceuticals LLC Main Business Overview 11.7.5 Dendreon Pharmaceuticals LLC Latest Developments 11.8 Eli Lilly & Company 11.8.1 Eli Lilly & Company Company Information 11.8.2 Eli Lilly & Company Precision Cancer Therapeutics Product Offered 11.8.3 Eli Lilly & Company Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.8.4 Eli Lilly & Company Main Business Overview 11.8.5 Eli Lilly & Company Latest Developments 11.9 EMD Serono, Inc. (Merck KgaA) 11.9.1 EMD Serono, Inc. (Merck KgaA) Company Information 11.9.2 EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Product Offered 11.9.3 EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.9.4 EMD Serono, Inc. (Merck KgaA) Main Business Overview 11.9.5 EMD Serono, Inc. (Merck KgaA) Latest Developments 11.10 Eisai Co., Ltd. 11.10.1 Eisai Co., Ltd. Company Information 11.10.2 Eisai Co., Ltd. Precision Cancer Therapeutics Product Offered 11.10.3 Eisai Co., Ltd. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.10.4 Eisai Co., Ltd. Main Business Overview 11.10.5 Eisai Co., Ltd. Latest Developments 11.11 Exelixis, Inc. 11.11.1 Exelixis, Inc. Company Information 11.11.2 Exelixis, Inc. Precision Cancer Therapeutics Product Offered 11.11.3 Exelixis, Inc. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.11.4 Exelixis, Inc. Main Business Overview 11.11.5 Exelixis, Inc. Latest Developments 11.12 Gilead Sciences, Inc. 11.12.1 Gilead Sciences, Inc. Company Information 11.12.2 Gilead Sciences, Inc. Precision Cancer Therapeutics Product Offered 11.12.3 Gilead Sciences, Inc. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.12.4 Gilead Sciences, Inc. Main Business Overview 11.12.5 Gilead Sciences, Inc. Latest Developments 11.13 GlaxoSmithKline 11.13.1 GlaxoSmithKline Company Information 11.13.2 GlaxoSmithKline Precision Cancer Therapeutics Product Offered 11.13.3 GlaxoSmithKline Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.13.4 GlaxoSmithKline Main Business Overview 11.13.5 GlaxoSmithKline Latest Developments 11.14 Johnson & Johnson 11.14.1 Johnson & Johnson Company Information 11.14.2 Johnson & Johnson Precision Cancer Therapeutics Product Offered 11.14.3 Johnson & Johnson Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.14.4 Johnson & Johnson Main Business Overview 11.14.5 Johnson & Johnson Latest Developments 11.15 Merck & Co., Inc. 11.15.1 Merck & Co., Inc. Company Information 11.15.2 Merck & Co., Inc. Precision Cancer Therapeutics Product Offered 11.15.3 Merck & Co., Inc. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.15.4 Merck & Co., Inc. Main Business Overview 11.15.5 Merck & Co., Inc. Latest Developments 11.16 Novartis AG 11.16.1 Novartis AG Company Information 11.16.2 Novartis AG Precision Cancer Therapeutics Product Offered 11.16.3 Novartis AG Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.16.4 Novartis AG Main Business Overview 11.16.5 Novartis AG Latest Developments 11.17 Otsuka Holdings Co., Ltd. 11.17.1 Otsuka Holdings Co., Ltd. Company Information 11.17.2 Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Product Offered 11.17.3 Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.17.4 Otsuka Holdings Co., Ltd. Main Business Overview 11.17.5 Otsuka Holdings Co., Ltd. Latest Developments 11.18 Pfizer, Inc. 11.18.1 Pfizer, Inc. Company Information 11.18.2 Pfizer, Inc. Precision Cancer Therapeutics Product Offered 11.18.3 Pfizer, Inc. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.18.4 Pfizer, Inc. Main Business Overview 11.18.5 Pfizer, Inc. Latest Developments 11.19 Puma Biotechnology, Inc. 11.19.1 Puma Biotechnology, Inc. Company Information 11.19.2 Puma Biotechnology, Inc. Precision Cancer Therapeutics Product Offered 11.19.3 Puma Biotechnology, Inc. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.19.4 Puma Biotechnology, Inc. Main Business Overview 11.19.5 Puma Biotechnology, Inc. Latest Developments 11.20 Roche (F. Hoffman-La Roche, Ltd.) 11.20.1 Roche (F. Hoffman-La Roche, Ltd.) Company Information 11.20.2 Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Product Offered 11.20.3 Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.20.4 Roche (F. Hoffman-La Roche, Ltd.) Main Business Overview 11.20.5 Roche (F. Hoffman-La Roche, Ltd.) Latest Developments 11.21 Sanofi/Genzyme 11.21.1 Sanofi/Genzyme Company Information 11.21.2 Sanofi/Genzyme Precision Cancer Therapeutics Product Offered 11.21.3 Sanofi/Genzyme Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.21.4 Sanofi/Genzyme Main Business Overview 11.21.5 Sanofi/Genzyme Latest Developments 11.22 Seagen Inc. 11.22.1 Seagen Inc. Company Information 11.22.2 Seagen Inc. Precision Cancer Therapeutics Product Offered 11.22.3 Seagen Inc. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.22.4 Seagen Inc. Main Business Overview 11.22.5 Seagen Inc. Latest Developments 11.23 Takeda 11.23.1 Takeda Company Information 11.23.2 Takeda Precision Cancer Therapeutics Product Offered 11.23.3 Takeda Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.23.4 Takeda Main Business Overview 11.23.5 Takeda Latest Developments 12 Research Findings and Conclusion
List of Tables Table 1. Precision Cancer Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions) Table 2. Precision Cancer Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Monoclonal Antibodies Table 4. Major Players of Kinase Inhibitors Table 5. Major Players of Angiogenesis Inhibitors Table 6. Major Players of Proteasome Inhibitors Table 7. Major Players of CAR-T Therapies Table 8. Major Players of Other Precision Therapies Table 9. Precision Cancer Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions) Table 10. Global Precision Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions) Table 11. Global Precision Cancer Therapeutics Market Size Market Share by Type (2020-2025) Table 12. Precision Cancer Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions) Table 13. Global Precision Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions) Table 14. Global Precision Cancer Therapeutics Market Size Market Share by Application (2020-2025) Table 15. Global Precision Cancer Therapeutics Revenue by Player (2020-2025) & ($ millions) Table 16. Global Precision Cancer Therapeutics Revenue Market Share by Player (2020-2025) Table 17. Precision Cancer Therapeutics Key Players Head office and Products Offered Table 18. Precision Cancer Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 19. New Products and Potential Entrants Table 20. Mergers & Acquisitions, Expansion Table 21. Global Precision Cancer Therapeutics Market Size by Region (2020-2025) & ($ millions) Table 22. Global Precision Cancer Therapeutics Market Size Market Share by Region (2020-2025) Table 23. Global Precision Cancer Therapeutics Revenue by Country/Region (2020-2025) & ($ millions) Table 24. Global Precision Cancer Therapeutics Revenue Market Share by Country/Region (2020-2025) Table 25. Americas Precision Cancer Therapeutics Market Size by Country (2020-2025) & ($ millions) Table 26. Americas Precision Cancer Therapeutics Market Size Market Share by Country (2020-2025) Table 27. Americas Precision Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions) Table 28. Americas Precision Cancer Therapeutics Market Size Market Share by Type (2020-2025) Table 29. Americas Precision Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions) Table 30. Americas Precision Cancer Therapeutics Market Size Market Share by Application (2020-2025) Table 31. APAC Precision Cancer Therapeutics Market Size by Region (2020-2025) & ($ millions) Table 32. APAC Precision Cancer Therapeutics Market Size Market Share by Region (2020-2025) Table 33. APAC Precision Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions) Table 34. APAC Precision Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions) Table 35. Europe Precision Cancer Therapeutics Market Size by Country (2020-2025) & ($ millions) Table 36. Europe Precision Cancer Therapeutics Market Size Market Share by Country (2020-2025) Table 37. Europe Precision Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions) Table 38. Europe Precision Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions) Table 39. Middle East & Africa Precision Cancer Therapeutics Market Size by Region (2020-2025) & ($ millions) Table 40. Middle East & Africa Precision Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions) Table 41. Middle East & Africa Precision Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions) Table 42. Key Market Drivers & Growth Opportunities of Precision Cancer Therapeutics Table 43. Key Market Challenges & Risks of Precision Cancer Therapeutics Table 44. Key Industry Trends of Precision Cancer Therapeutics Table 45. Global Precision Cancer Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions) Table 46. Global Precision Cancer Therapeutics Market Size Market Share Forecast by Region (2026-2031) Table 47. Global Precision Cancer Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions) Table 48. Global Precision Cancer Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions) Table 49. AbbVie Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 50. AbbVie Precision Cancer Therapeutics Product Offered Table 51. AbbVie Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 52. AbbVie Main Business Table 53. AbbVie Latest Developments Table 54. Astellas Pharma U.S., Inc Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 55. Astellas Pharma U.S., Inc Precision Cancer Therapeutics Product Offered Table 56. Astellas Pharma U.S., Inc Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 57. Astellas Pharma U.S., Inc Main Business Table 58. Astellas Pharma U.S., Inc Latest Developments Table 59. AstraZeneca PLC Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 60. AstraZeneca PLC Precision Cancer Therapeutics Product Offered Table 61. AstraZeneca PLC Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 62. AstraZeneca PLC Main Business Table 63. AstraZeneca PLC Latest Developments Table 64. Bayer AG Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 65. Bayer AG Precision Cancer Therapeutics Product Offered Table 66. Bayer AG Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 67. Bayer AG Main Business Table 68. Bayer AG Latest Developments Table 69. Bristol-Myers Squibb Company Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 70. Bristol-Myers Squibb Company Precision Cancer Therapeutics Product Offered Table 71. Bristol-Myers Squibb Company Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 72. Bristol-Myers Squibb Company Main Business Table 73. Bristol-Myers Squibb Company Latest Developments Table 74. Clovis Oncology, Inc. Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 75. Clovis Oncology, Inc. Precision Cancer Therapeutics Product Offered Table 76. Clovis Oncology, Inc. Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 77. Clovis Oncology, Inc. Main Business Table 78. Clovis Oncology, Inc. Latest Developments Table 79. Dendreon Pharmaceuticals LLC Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 80. Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Product Offered Table 81. Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 82. Dendreon Pharmaceuticals LLC Main Business Table 83. Dendreon Pharmaceuticals LLC Latest Developments Table 84. Eli Lilly & Company Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 85. Eli Lilly & Company Precision Cancer Therapeutics Product Offered Table 86. Eli Lilly & Company Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 87. Eli Lilly & Company Main Business Table 88. Eli Lilly & Company Latest Developments Table 89. EMD Serono, Inc. (Merck KgaA) Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 90. EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Product Offered Table 91. EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 92. EMD Serono, Inc. (Merck KgaA) Main Business Table 93. EMD Serono, Inc. (Merck KgaA) Latest Developments Table 94. Eisai Co., Ltd. Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 95. Eisai Co., Ltd. Precision Cancer Therapeutics Product Offered Table 96. Eisai Co., Ltd. Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 97. Eisai Co., Ltd. Main Business Table 98. Eisai Co., Ltd. Latest Developments Table 99. Exelixis, Inc. Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 100. Exelixis, Inc. Precision Cancer Therapeutics Product Offered Table 101. Exelixis, Inc. Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 102. Exelixis, Inc. Main Business Table 103. Exelixis, Inc. Latest Developments Table 104. Gilead Sciences, Inc. Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 105. Gilead Sciences, Inc. Precision Cancer Therapeutics Product Offered Table 106. Gilead Sciences, Inc. Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 107. Gilead Sciences, Inc. Main Business Table 108. Gilead Sciences, Inc. Latest Developments Table 109. GlaxoSmithKline Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 110. GlaxoSmithKline Precision Cancer Therapeutics Product Offered Table 111. GlaxoSmithKline Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 112. GlaxoSmithKline Main Business Table 113. GlaxoSmithKline Latest Developments Table 114. Johnson & Johnson Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 115. Johnson & Johnson Precision Cancer Therapeutics Product Offered Table 116. Johnson & Johnson Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 117. Johnson & Johnson Main Business Table 118. Johnson & Johnson Latest Developments Table 119. Merck & Co., Inc. Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 120. Merck & Co., Inc. Precision Cancer Therapeutics Product Offered Table 121. Merck & Co., Inc. Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 122. Merck & Co., Inc. Main Business Table 123. Merck & Co., Inc. Latest Developments Table 124. Novartis AG Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 125. Novartis AG Precision Cancer Therapeutics Product Offered Table 126. Novartis AG Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 127. Novartis AG Main Business Table 128. Novartis AG Latest Developments Table 129. Otsuka Holdings Co., Ltd. Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 130. Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Product Offered Table 131. Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 132. Otsuka Holdings Co., Ltd. Main Business Table 133. Otsuka Holdings Co., Ltd. Latest Developments Table 134. Pfizer, Inc. Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 135. Pfizer, Inc. Precision Cancer Therapeutics Product Offered Table 136. Pfizer, Inc. Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 137. Pfizer, Inc. Main Business Table 138. Pfizer, Inc. Latest Developments Table 139. Puma Biotechnology, Inc. Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 140. Puma Biotechnology, Inc. Precision Cancer Therapeutics Product Offered Table 141. Puma Biotechnology, Inc. Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 142. Puma Biotechnology, Inc. Main Business Table 143. Puma Biotechnology, Inc. Latest Developments Table 144. Roche (F. Hoffman-La Roche, Ltd.) Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 145. Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Product Offered Table 146. Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 147. Roche (F. Hoffman-La Roche, Ltd.) Main Business Table 148. Roche (F. Hoffman-La Roche, Ltd.) Latest Developments Table 149. Sanofi/Genzyme Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 150. Sanofi/Genzyme Precision Cancer Therapeutics Product Offered Table 151. Sanofi/Genzyme Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 152. Sanofi/Genzyme Main Business Table 153. Sanofi/Genzyme Latest Developments Table 154. Seagen Inc. Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 155. Seagen Inc. Precision Cancer Therapeutics Product Offered Table 156. Seagen Inc. Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 157. Seagen Inc. Main Business Table 158. Seagen Inc. Latest Developments Table 159. Takeda Details, Company Type, Precision Cancer Therapeutics Area Served and Its Competitors Table 160. Takeda Precision Cancer Therapeutics Product Offered Table 161. Takeda Precision Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 162. Takeda Main Business Table 163. Takeda Latest Developments List of Figures Figure 1. Precision Cancer Therapeutics Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Precision Cancer Therapeutics Market Size Growth Rate (2020-2031) ($ millions) Figure 6. Precision Cancer Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 7. Precision Cancer Therapeutics Sales Market Share by Country/Region (2024) Figure 8. Precision Cancer Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 9. Global Precision Cancer Therapeutics Market Size Market Share by Type in 2024 Figure 10. Precision Cancer Therapeutics in Breast Cancer Figure 11. Global Precision Cancer Therapeutics Market: Breast Cancer (2020-2025) & ($ millions) Figure 12. Precision Cancer Therapeutics in Lung Cancer Figure 13. Global Precision Cancer Therapeutics Market: Lung Cancer (2020-2025) & ($ millions) Figure 14. Precision Cancer Therapeutics in Prostate Cancer Figure 15. Global Precision Cancer Therapeutics Market: Prostate Cancer (2020-2025) & ($ millions) Figure 16. Precision Cancer Therapeutics in Colon and Rectal Cancer Figure 17. Global Precision Cancer Therapeutics Market: Colon and Rectal Cancer (2020-2025) & ($ millions) Figure 18. Precision Cancer Therapeutics in Others Figure 19. Global Precision Cancer Therapeutics Market: Others (2020-2025) & ($ millions) Figure 20. Global Precision Cancer Therapeutics Market Size Market Share by Application in 2024 Figure 21. Global Precision Cancer Therapeutics Revenue Market Share by Player in 2024 Figure 22. Global Precision Cancer Therapeutics Market Size Market Share by Region (2020-2025) Figure 23. Americas Precision Cancer Therapeutics Market Size 2020-2025 ($ millions) Figure 24. APAC Precision Cancer Therapeutics Market Size 2020-2025 ($ millions) Figure 25. Europe Precision Cancer Therapeutics Market Size 2020-2025 ($ millions) Figure 26. Middle East & Africa Precision Cancer Therapeutics Market Size 2020-2025 ($ millions) Figure 27. Americas Precision Cancer Therapeutics Value Market Share by Country in 2024 Figure 28. United States Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 29. Canada Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 30. Mexico Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 31. Brazil Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 32. APAC Precision Cancer Therapeutics Market Size Market Share by Region in 2024 Figure 33. APAC Precision Cancer Therapeutics Market Size Market Share by Type (2020-2025) Figure 34. APAC Precision Cancer Therapeutics Market Size Market Share by Application (2020-2025) Figure 35. China Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 36. Japan Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 37. South Korea Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 38. Southeast Asia Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 39. India Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 40. Australia Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 41. Europe Precision Cancer Therapeutics Market Size Market Share by Country in 2024 Figure 42. Europe Precision Cancer Therapeutics Market Size Market Share by Type (2020-2025) Figure 43. Europe Precision Cancer Therapeutics Market Size Market Share by Application (2020-2025) Figure 44. Germany Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 45. France Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 46. UK Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 47. Italy Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 48. Russia Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 49. Middle East & Africa Precision Cancer Therapeutics Market Size Market Share by Region (2020-2025) Figure 50. Middle East & Africa Precision Cancer Therapeutics Market Size Market Share by Type (2020-2025) Figure 51. Middle East & Africa Precision Cancer Therapeutics Market Size Market Share by Application (2020-2025) Figure 52. Egypt Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 53. South Africa Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 54. Israel Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 55. Turkey Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 56. GCC Countries Precision Cancer Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 57. Americas Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 58. APAC Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 59. Europe Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 60. Middle East & Africa Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 61. United States Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 62. Canada Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 63. Mexico Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 64. Brazil Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 65. China Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 66. Japan Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 67. Korea Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 68. Southeast Asia Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 69. India Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 70. Australia Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 71. Germany Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 72. France Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 73. UK Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 74. Italy Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 75. Russia Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 76. Egypt Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 77. South Africa Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 78. Israel Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 79. Turkey Precision Cancer Therapeutics Market Size 2026-2031 ($ millions) Figure 80. Global Precision Cancer Therapeutics Market Size Market Share Forecast by Type (2026-2031) Figure 81. Global Precision Cancer Therapeutics Market Size Market Share Forecast by Application (2026-2031) Figure 82. GCC Countries Precision Cancer Therapeutics Market Size 2026-2031 ($ millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie|||Astellas Pharma U.S., Inc|||AstraZeneca PLC|||Bayer AG|||Bristol-Myers Squibb Company|||Clovis Oncology, Inc.|||Dendreon Pharmaceuticals LLC|||Eli Lilly & Company|||EMD Serono, Inc. (Merck KgaA)|||Eisai Co., Ltd.|||Exelixis, Inc.|||Gilead Sciences, Inc.|||GlaxoSmithKline|||Johnson & Johnson|||Merck & Co., Inc.|||Novartis AG|||Otsuka Holdings Co., Ltd.|||Pfizer, Inc.|||Puma Biotechnology, Inc.|||Roche (F. Hoffman-La Roche, Ltd.)|||Sanofi/Genzyme|||Seagen Inc.|||Takeda